[Minocycline for the treatment of bronchiolitis obliterans associated with rheumatoid arthritis]. 2001

C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
Department of Internal Medicine & Radiology, Saint Marianna University School of Medicine, Kawasaki-city, Kanagawa.

We discribe a rare case of rheumatoid arthritis (RA) complicated with bronchiolitis obliterans that was successfully treated with minocycline. Sixty four-year old woman with a four-years history of RA was admitted to the hospital because of dyspnea on exertion and polyarthritis. Pulmonary function test revealed marked decrease in V25 (0.10 l/s: 6.9%) and MMFR (12.6%). High resolution CT of the lung showed scattered centri-lobular micronodules in both lung fields, mucoid impaction, and hyperinflation. These findings indicated the presence of bronchiolitis obliterans. After 3 months of the treatment with minocycline, the patient showed a significant improvement of both arthritis and pulmonary function. Chest CT findings also improved after 1 year. The present case suggests that minocycline is effective for the treatment of bronchiolitis obliterans seen in patients with RA.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008911 Minocycline A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections. Akamin,Akne-Puren,Aknemin,Aknin-Mino,Aknosan,Apo-Minocycline,Arestin,Blemix,Cyclomin,Cyclops,Dentomycin,Dynacin,Icht-Oral,Klinomycin,Lederderm,Mestacine,Minakne,Mino-Wolff,Minocin,Minocin MR,Minoclir,Minocycline Hydrochloride,Minocycline Monohydrochloride,Minocycline, (4R-(4 alpha,4a beta,5a beta,12a beta))-Isomer,Minolis,Minomycin,Minoplus,Minotab,Minox 50,Mynocine,Akne Puren,Aknin Mino,Apo Minocycline,Hydrochloride, Minocycline,Icht Oral,Mino Wolff,Monohydrochloride, Minocycline
D001989 Bronchiolitis Obliterans Inflammation of the BRONCHIOLES leading to an obstructive lung disease. Bronchioles are characterized by fibrous granulation tissue with bronchial exudates in the lumens. Clinical features include a nonproductive cough and DYSPNEA. Bronchiolitis, Exudative,Bronchiolitis, Proliferative,Constrictive Bronchiolitis,Exudative Bronchiolitis,Proliferative Bronchiolitis,Bronchiolitides, Constrictive,Bronchiolitides, Exudative,Bronchiolitides, Proliferative,Bronchiolitis, Constrictive,Constrictive Bronchiolitides,Exudative Bronchiolitides,Proliferative Bronchiolitides
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
March 1982, Clinical rheumatology,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
February 1988, Revista medica de Chile,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
April 1994, The European respiratory journal,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
January 1997, Archives of dermatology,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
August 1993, Seminars in arthritis and rheumatism,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
July 1991, The European respiratory journal,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
June 2004, Clinical rheumatology,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
September 1991, Nihon Kyobu Shikkan Gakkai zasshi,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
November 1996, Nihon Kyobu Shikkan Gakkai zasshi,
C Kase, and M Okubo, and M Yamasaki, and H Yamada, and Y Suzuki, and N Hama, and Y Ichikawa, and K Sasaka, and Y Nakajima
January 1994, Journal of computer assisted tomography,
Copied contents to your clipboard!